BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260121T231108EST-1990BALIbu@132.216.98.100
DTSTAMP:20260122T041108Z
DESCRIPTION:Le Groupe de recherchen en santé et droit de ɬÀï·¬ (GRSD) et l
 'Institut de recherche sur les politiques sociales et de santé (IRPS) sont
  fiers d'accueuillir Thomas Pogge pour la 6e conférence annuelle du GRSD.
 \nLe professeur Thomas Pogge dirige le Programme de justice globale et est
  titulaire de la chaire Leitner en philosophie et en affaire international
 es à l'Université Yale.\nLa conférence est gratuite et ouverte au public. 
 Toutefois\, comme le nombre de places est limité\, nous vous prions de rés
 erver votre place en écrivant à rghl.law [at] mcgill.ca.\nCette activité e
 st accréditée par le Barreau du Québec pour 1\,5 heures de formation conti
 nue pour juristes (activité no. 10075976). Prière d'indiquer si vous êtes 
 membre du Barreau dans votre RSVP.\nRésumé \n(En anglais seulement). One-t
 hird of all human lives end in early death from poverty-related causes. Ma
 ny of these premature deaths are avoidable through global health system re
 forms\, including to the existing patent regime. The latter provides incen
 tives for the development and distribution of new medicines\; but it also 
 leaves gaps\, especially in poor regions. The Health Impact Fund (HIF) is 
 a mechanism intended to fill these gaps and to improve access to new medic
 ines worldwide.\nThe HIF would give pharmaceutical innovators the option t
 o be rewarded according to the incremental health impact of their product 
 rather than through a patent-protected mark-up. The HIF would stimulate th
 e development of high-impact medicines (especially for currently neglected
  diseases)\, would ensure availability at low cost\, and would encourage i
 nnovators to market such medicines with the aim of reducing the global dis
 ease burden.\nThe feasibility of this reform shows that the existing medic
 al-patent regime is severely unjust. Professor Pogge will (a) introduce th
 e HIF proposal and its moral justification\, (b) discuss its implementatio
 n\, funding\, and economic viability\, (c) explain its advantages for phar
 maceutical firms as well as the benefits for the health and welfare of aff
 luent and poor populations and (d) report on efforts to pilot the HIF idea
  in particular jurisdictions.\nLe conférencier\n (En anglais seulement). H
 aving received his PhD in philosophy from Harvard\, Thomas Pogge is Leitne
 r Professor of Philosophy and International Affairs and Director of the Gl
 obal Justice Program at Yale. He is a member of the Norwegian Academy of S
 cience as well as President of Academics Stand Against Poverty (ASAP)\, an
  international network aiming to enhance the impact of scholars\, teachers
  and students on global poverty\, and of Incentives for Global Health\, a 
 team effort toward developing a complement to the pharmaceutical patent re
 gime that would improve access to advanced medicines for the poor worldwid
 e (www.healthimpactfund.org). Pogge's recent publications include Politics
  as Usual (Polity 2010)\; World Poverty and Human Rights (Polity 2008)\; J
 ohn Rawls: His Life and Theory of Justice (Oxford 2007)\; and Freedom from
  Poverty as a Human Right (Oxford & UNESCO 2007).
DTSTART:20131011T183000Z
DTEND:20131011T200000Z
LOCATION:Maxwell Cohen Moot Court (room 100)\, Pavillon Chancellor-Day\, CA
 \, QC\, Montréal\, H3A 1W9\, 3644\, rue Peel
SUMMARY:Conférence annuelle GRSD/IRPC avec Thomas Pogge: Payer pour le 'Hea
 lth Impact Fund'
URL:/channels/fr/event/noter-votre-agenda-conference-a
 nnuelle-grsdirpc-avec-thomas-pogge-229885
END:VEVENT
END:VCALENDAR